Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue
Conditions
Interventions
Intervention1: nil: nil
Sponsors
Pfizer Inc.
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with inflammatory arthritis such as Rheumatoid arthritis (RA)and Spondyloarthritis(SpA) Primary health care providers involved in care of such patients
Exclusion criteria
Exclusion criteria: Non-immune mediated arthritis such as gout, osteo-arthritis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We expect to achieve more than 80 percent improvement in medication-adherence and treat to target outcomes in arthritis patients as dictated by international guidelines. Through educating primary care providers, we expect to reduce time to diagnosis, treatment initiation and improve rheumatology referrals in inflammatory arthritis (Rheumatoid Arthritis, Spondyloarthritis).Timepoint: 4 months | — |
Secondary
| Measure | Time frame |
|---|---|
| A. Develop and implement a scalable and replicable patient education model for hospitals treating AIRDs in low- and middle-income settings. B. Access to high quality care irrespective of socioeconomic or cultural setting for patients with AIRDs. C. Improve clinical practice with respect to diagnosis and treatment of AIRDs among primary care physicians caring for AIRD patients. D. Inform and improve referral services for AIRD patients in remote areas. Timepoint: 16 months | — |
Countries
India
Contacts
Public ContactShaleni
St Johns Medical College and Hospital
Outcome results
None listed